Type 3 Gaucher disease

DBCOND0020405Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System Diseases

Type 3 Gaucher disease is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Gaucher's disease type III · Gaucher Disease, Type 3 · Gaucher Disease Type 3 · Gaucher Disease, Type III
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0335238SNOMED CT5963005MedDRA10075699UMLSC0268251

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
17Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Type 3 Gaucher disease share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In